4SM

TETRATHIOMOLYBDATE


Toggle HydrogenToggle Labels

Chemical Component Summary

NameTETRATHIOMOLYBDATE
Identifiersbis(sulfanidyl)-bis(sulfanylidene)molybdenum
FormulaMo S4
Molecular Weight224.2
TypeNON-POLYMER
Isomeric SMILES[S-][Mo](=S)(=S)[S-]
InChIInChI=1S/Mo.4S/q;;;2*-1
InChIKeyCXVCSRUYMINUSF-UHFFFAOYSA-N

Chemical Details

Formal Charge-2
Atom Count5
Chiral Atom Count0
Bond Count4
Aromatic Bond Count0

Drug Info: DrugBank

DrugBank IDDB05088 
NameTetrathiomolybdate
Groups investigational
DescriptionTetrathiomolybdate is an oral, small-molecule, anticopper agent that is highly specific for lowering the levels of free copper in serum. COPREXA has completed pivotal clinical trials for the treatment of neurologic Wilson's disease. It is also developed for fibrotic disorders based upon the rationale that the fibrotic disease process is dependent upon the availability of free copper in the body.
Synonyms
  • Tiomolibdate ion
  • Choline tetrathiomolybdate
  • Thiomolybdate
  • Tetrathiomolybdate
IndicationInvestigated for use/treatment in liver disease and pulmonary fibrosis.
Categories
  • Adenosine Triphosphatases, antagonists & inhibitors
  • Angiogenesis Modulating Agents
  • Antineoplastic Agents
  • Chelating Agents
  • Compounds used in a research, industrial, or household setting
CAS number16330-92-0

Drug Targets

NameTarget SequencePharmacological ActionActions
Amyloid beta A4 proteinMLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNG...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSD NAMXOP, AMEHEF01, FESTON, COXTUF, MIRXAN, JAYJEZ, LIVLUY, PIPTMO01, LIVLOS, CADLUP, LIVLIM, FESTIH, MUGDUO, EVIREG, KIBLOX, IBOCOR, HIPZOV02, BUNNUT02, PEWYIA, OYUBOC, OYUBIW, OYUBUI, OYUBES